
Financial derivatives exchange CME Group (NASDAQ: CME) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.1% year on year to $1.65 billion. Its non-GAAP profit of $2.77 per share was 1% above analysts’ consensus estimates.
Is now the time to buy CME? Find out in our full research report (it’s free for active Edge members).
CME Group (CME) Q4 CY2025 Highlights:
- Revenue: $1.65 billion vs analyst estimates of $1.64 billion (8.1% year-on-year growth, in line)
- Adjusted EPS: $2.77 vs analyst estimates of $2.74 (1% beat)
- Adjusted EBITDA: $1.13 billion vs analyst estimates of $1.13 billion (68.6% margin, in line)
- Operating Margin: 61.8%, in line with the same quarter last year
- Market Capitalization: $106.2 billion
StockStory’s Take
CME Group’s fourth quarter results aligned with Wall Street expectations, supported by broad-based growth across asset classes and expansion in retail participation. Management pointed to increased activity in interest rate, energy, metals, agricultural, and cryptocurrency products as key drivers. CEO Terrence Duffy emphasized that the launch of new event contracts and strong performance in retail-focused micro products contributed meaningfully to quarterly momentum. The company also highlighted the resilience and diversification of its customer base, noting continued healthy engagement from both institutional and retail clients amid volatile market conditions.
Looking ahead, CME Group’s management is focused on launching major initiatives such as securities clearing and 24/7 crypto trading, projects expected to drive new business and client engagement. The upcoming introduction of additional cryptocurrency futures and continued expansion of event contracts are designed to attract new user segments while maintaining capital efficiency for existing clients. CFO Lynne Fitzpatrick noted, “We are dedicated to continuously evolving our product set and offering, a commitment that requires strategic investment for growth.” Management also cautioned that expense growth will track these investments, with special attention to balancing innovation and cost discipline.
Key Insights from Management’s Remarks
Management credited the quarter’s performance to strong execution in retail and crypto products, new product launches, and sustained market data revenue growth.
- Retail product momentum: The launch of event contracts on financial, commodity, and sports markets brought in new traders, with over 68 million contracts traded in the first six weeks and micro product volumes up 59% year-over-year in Q4.
- Cryptocurrency expansion: CME set a new record in crypto trading, with daily volumes up 92% and exceeding $13 billion in notional value traded per day. Additional crypto futures products, including Cardano, Chainlink, and Stellar, are planned, alongside the rollout of 24/7 trading access.
- Market data revenue strength: Market data revenue grew 15%, driven by a combination of new user expansion, product innovation (such as new data sets and cloud-based delivery), and pricing integrity. This recurring revenue stream saw contributions from both retail and institutional clients.
- Securities clearing and cross-margining: CME received regulatory approval to launch a new securities clearinghouse and plans to extend cross-margining services to end-user clients, which management believes will deliver significant capital efficiencies.
- Pricing strategy changes: Transaction fee adjustments, especially in metals, micros, and crude oil, are expected to incrementally lift revenue. Management stated that pricing reviews will now occur throughout the year rather than just annually, reflecting a more dynamic approach.
Drivers of Future Performance
CME’s outlook hinges on continued product expansion, regulatory changes, and investments in technology to support long-term growth and operational leverage.
- Product and market innovation: New offerings such as 24/7 crypto trading, event contracts, and additional futures products are expected to attract new customer segments and increase trading activity, supporting revenue and margin stability.
- Regulatory and infrastructure advancements: The launch of CME securities clearing and expansion of cross-margining, pending full regulatory approval, are intended to provide capital efficiencies and draw new institutional clients, potentially increasing collateral balances and market share.
- Expense management and strategic investment: Management anticipates higher expenses in 2026 due to investments in new initiatives and technology, including the Google Cloud migration. However, they expect these investments to underpin scalable growth while maintaining a disciplined approach to cost control.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will closely monitor (1) the adoption and revenue contribution from new crypto and event contract products, (2) regulatory progress on securities clearing and cross-margining initiatives, and (3) the impact of dynamic pricing and fee adjustments across core asset classes. The scalability and efficiency of ongoing technology investments, such as the Google Cloud migration, will also be important markers of CME’s operational execution.
CME Group currently trades at $294.51, in line with $293.07 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
